Xstrahl is the world’s leading designer and manufacturer of superficial orthovoltage medical X-ray systems, used in the treatment of cancers and dermatological disorders, and a leading pioneer and developer of advanced X-ray systems for pre-clinical radiation biology research. Headquartered in the UK with manufacturing facilities and offices in the UK, USA & Germany. Xstrahl also operates globally through its international network of distributors.
For over 20 years, the comprehensive range of Xstrahl’s superficial and orthovoltage X-ray therapy systems (Xstrahl 100, 150, 200 and 300) have reliably supported the X-ray therapy requirements of healthcare professionals and their patients in over 700 clinics in 80 different countries around the world. Xstrahl have grown to be the leading designer and manufacturer of medical solutions that provide nonsurgical alternatives for patients with non-melanoma skin cancer, and treatment of benign and palliative conditions.
Xstrahl designs and delivers innovative X-ray research solutions to advance radiation oncology. Xstrahl’s pioneering X-ray research solutions include custom cabinet irradiators that are used for delivering precise radiation doses to in vivo and in vitro biological specimens, and the industry–leading Small Animal Radiation Research Platform (SARRP) image guided irradiator with high resolution imaging, and X-ray calibration systems used for calibrating laboratory X-ray research systems.
Adrian had more than 10 years of industry leadership experience before coming to Xstrahl, as an International sales manager in 2006. As Sales Director, he took the lead on building up Xstrahl’s distributor network and growing the US subsidiary, ultimately moving to the USA in 2011 to continue his work with the Life Science brand. In 2013 Adrian was appointed Chief Operations Officer and continued to build a strong team around him. In 2017 after a management buy out Adrian was promoted to Group CEO.